Neumarz Market Outlook January 2026
2026 M&A trends: why European and Swiss buyers are targeting US assets, plus outlook on healthcare, financial services, and energy consolidation.
Read More
Neumarz Market Intelligence Brief – November 2025
November 2025 encapsulates that transition. Markets reward foresight, governance and technical mastery. Corporations operating between Switzerland, Western Europe and the United States stand at the frontier of that transformation. Liquidity endures, but leadership belongs to those who know how to use it.
Read More
Switzerland’s Venture Capital Reality Check: A Biotech Mirage in a Hollowed Ecosystem
This article is an analysis of the SECA Venture Capital 2025 Mid-Year Report. Switzerland’s venture capital performance in the first half of 2025 appears solid on the surface. Invested capital rose 36% year-on-year to CHF 1.47 billion. Yet beneath this surge lies a fragile reality: deal volume continues...
Read More